Maxygen, Inc. · Redwood City, CA United States (NASDAQ: MAXY)
| 515 Galveston Dr. | Phone: 650-298-5300 |
| Redwood City, CA | Fax: 650-364-2715 |
| 94063 | |
| United States | 
Map This Company |
Maxygen, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Maxygen dedicates itself to maximizing the potential of protein-based pharmaceuticals. The company develops improved versions of existing protein compounds that treat autoimmune diseases like rheumatoid arthritis, as well as help fight transplant rejection (through lead candidate MAXY-4). Maxygen conducted most of its research and development through Perseid Therapeutics, which it operated as a joint venture agreement with
Maxygen, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: MAXY Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 69 |
Executives
10 executives listed for Maxygen, Inc.'s Redwood City, CA location.
| Chairman | Isaac Stein | |
|---|---|---|
| CEO, CFO, and Director | James Sulat | |
| Associate Director | Madan Paidhungat |